Effect of Denosumab Compared With Risedronate on Bone Strength in Patients Initiating or Continuing Glucocorticoid Treatment
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Bone and Mineral Research"
DOI: 10.1002/jbmr.4551
Abstract: In a randomized clinical trial in patients initiating glucocorticoid therapy (GC‐I) or on long‐term therapy (GC‐C), denosumab every 6 months increased spine and hip bone mineral density at 12 and 24 months significantly more than… read more here.
Keywords: patients initiating; denosumab; denosumab compared; bone ... See more keywords
Efficacy and safety of denosumab compared to bisphosphonates in improving bone strength in postmenopausal osteoporosis: a systematic review.
Sign Up to like & getrecommendations! Published in 2019 at "Singapore medical journal"
DOI: 10.11622/smedj.2019028
Abstract: INTRODUCTION Osteoporosis is the main cause of fractures among women after menopause. This study aimed to evaluate the efficacy and safety of denosumab compared to bisphosphonates in treating postmenopausal osteoporosis. METHODS Databases including PubMed and… read more here.
Keywords: efficacy safety; denosumab; bone; postmenopausal osteoporosis ... See more keywords